Close Menu

NEW YORK (GenomeWeb) – A team led by Boston University researchers has received a seven-year, $15.9 million grant from the National Institutes of Health to develop methods for detecting and diagnosing chronic traumatic encephalopathy (CTE).

CTE is a neurodegenerative disease characterized by the accumulation of abnormal tau protein in the brain. It is commonly associated with repetitive head injuries, such as those sustained in boxing or football, and is currently only diagnosable through post-mortem brain dissection.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.